| Journal Profile | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Journal Title | HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | ||||||||||||||||||||
| Journal Title Abbreviations | HEMATOL ONCOL CLIN N | ||||||||||||||||||||
| ISSN | 0889-8588 | ||||||||||||||||||||
| E-ISSN | 1558-1977 | ||||||||||||||||||||
| h-index | 74 | ||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||
| Self-Citation Ratio (2019-2020) | 3.00% | ||||||||||||||||||||
| Official Website | https://www.elsevier.com/journals/hematology-oncology-clinics-of-north-america/0889-8588 | ||||||||||||||||||||
| Online Manuscript Submission | https://www.elsevier.com/authors/journal-authors/submit-your-paper | ||||||||||||||||||||
| Open Access | No | ||||||||||||||||||||
| Publisher | W B SAUNDERS CO-ELSEVIER INC, 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, USA, PA, 19103-2899 | ||||||||||||||||||||
| Subject Area | Medicine | ||||||||||||||||||||
| Country/Area of Publication | UNITED STATES | ||||||||||||||||||||
| Publication Frequency | Bimonthly | ||||||||||||||||||||
| Year Publication Started | 1987 | ||||||||||||||||||||
| Annual Article Volume | 73 | ||||||||||||||||||||
| Indexing (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
| Link to PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0889-8588%5BISSN%5D | ||||||||||||||||||||
| Average Duration of Peer Review * | Authorized Data from Publisher: Data from Authors: Slow, 6-12 Week(s) | ||||||||||||||||||||
| Competitiveness * | Data from Authors: Moderate | ||||||||||||||||||||
| Useful Links |
| ||||||||||||||||||||
| *All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. As such they may not reflect the journals' exact competitiveness or speed. | |||||||||||||||||||||
|
|
| |